Navigation Links
Boston Healthcare Associates Roundtable Explores Challenges and Opportunities Surrounding the Value of Big Data within the Life Sciences
Date:5/24/2012

BOSTON, May 24, 2012 /PRNewswire-iReach/ -- Boston Healthcare Associates hosted a roundtable May 16th to discuss the unique challenges and opportunities surrounding the growing volume of big data in the life sciences and how best to utilize its full potential. "Big data" being defined as large sets of data whose size exceeds conventional abilities for effective capture, storage, and analysis.

The increasing volume of life science and health care data offers exciting opportunities for innovators, manufacturers, stakeholders, providers, and patients - but it also poses new challenges. The rising torrent of big data is currently revolutionary in its volume, variety, and potential value. However, the rapid expansion of data, by people and machines, as well as a need for new resources and structures for storage and interpretation, is adding more and more complexity to the task of trying to effectively aggregate and leverage information into actionable insights.   

The roundtable discussed these issues as well as the emerging importance of big data and its potential implications on innovation. Several questions were addressed including: What is unique about big data within the life sciences? Who should have access and control? How should we address patient consent? Will big data drive change in policy/regulation, and ultimately science? What type of investments and resources are needed? What new insights will be drawn? And how quickly will those insights drive real-time decision-making?

"We've entered an era of information explosion in which our capacity to generate data is exceeding our ability to store, process, and use it," said Andrew Ferrara, CEO of Boston Healthcare Associates. "Aggregating and processing this data into meaningful information is key to driving better decisions and swifter outcomes in innovation - translating to better care for patients."

Today's roundtable included a cross-disciplinary group of life science leaders, all working at the forefront of innovation:

  • Andrew Ferrara, CEO, Boston Healthcare
  • Christopher Twardowski, Director Client Services, Boston Healthcare
  • Andrew Tarab, Director Health Economics, Boston Healthcare
  • Dr. Ulrich Goldmann, Senior Vice President, Global Medical Operations, Genzyme, a Sanofi company
  • Michael Braxenthaler, President of Pistoia Alliance; Strategic Alliances, Pharma Research & Early Development Informatics, Roche
  • Dr. Jens Hoefkens, Head of Genedata Expressionist Unit, Genedata
  • Christopher McClure, Business Development & Account Management, Genedata
  • Melli Annamalai, Senior Principal Product Manager, Oracle Database Server Technologies
  • Dave Greenwald, Managing Director, Relay Technology Management
  • Richard Dale, Principal, Sigma Partners

A summary of the roundtable meeting discussion is available for download here.

About Boston Healthcare Associates

Boston Healthcare assists emerging and established biopharmaceutical, medical device, and diagnostic companies worldwide in gaining a competitive advantage in the health care marketplace by helping them unlock the value of their innovations. These companies rely on Boston Healthcare to create opportunities, navigate complexity, grow their businesses, and achieve objectives through reimbursement and market access strategy services, health economics and outcomes research, market analytics and pricing strategy, and business development support services. Clients draw on Boston Healthcare's unique approach to gain a real-world edge in a highly competitive health care environment. For more information, visit www.bostonhealthcare.com

Media Contact: Michal Taton Boston Healthcare, 617-912-5119, mtaton@bostonhealthcare.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Boston Healthcare
Copyright©2010 PR Newswire.
All rights reserved

Related biology news :

1. Attendees Save Up To $800 on Boston-area Pharmaceutical and Healthcare Conferences, Early Bird Discounts Expiring April 27
2. Annual Drug Discovery Conferences Being Held in Boston MA, Spring 2012
3. Boston College names Thomas Chiles the Deluca Professor of Biology
4. 4 Boston College faculty members named Sloan Research Fellows
5. Boston University researchers develop novel drug delivery system
6. Boston University School of Medicine researchers clarify link between salt and hypertension
7. Boston University School of Medicine professor honored by American College of Nutrition
8. Register now! Boston meeting will showcase latest aging discoveries
9. NIH training grant awarded to Boston University School of Medicine and College of Engineering
10. Join GSA in Boston for the nations premier aging conference
11. BU researchers identify extensive methane leaks under streets of Boston
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/15/2016)... 15, 2016  A new partnership announced today ... underwriting decisions in a fraction of the time ... and high-value life insurance policies to consumers without ... With Force Diagnostics, rapid testing (A1C, Cotinine and ... (blood pressure, weight, pulse, BMI, and activity data) ...
(Date:3/31/2016)... 2016   LegacyXChange, ... "Company") LegacyXChange is excited to release its ... to be launched online site for trading 100% guaranteed ... will also provide potential shareholders a sense of the ... an industry that is notorious for fraud. The video ...
(Date:3/22/2016)... PUNE, India , March 22, 2016 ... new market research report "Electronic Sensors Market for ... Fingerprint, Proximity, & Others), Application (Communication & ... and Geography - Global Forecast to 2022", ... consumer industry is expected to reach USD ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... --  Ginkgo Bioworks , a leading organism design ... awarded as one of the World Economic Forum,s ... innovative companies. Ginkgo Bioworks is engineering biology to ... in the nutrition, health and consumer goods sectors. ... including Fortune 500 companies to design microbes for ...
(Date:6/24/2016)... June 24, 2016 Epic Sciences unveiled ... cancers susceptible to PARP inhibitors by targeting homologous ... (CTCs). The new test has already been incorporated ... multiple cancer types. Over 230 clinical ... response pathways, including PARP, ATM, ATR, DNA-PK and ...
(Date:6/24/2016)... ... , ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical ... mesothelioma. Their findings are the subject of a new article on the Surviving Mesothelioma ... in the blood, lung fluid or tissue of mesothelioma patients that can help point ...
(Date:6/23/2016)... Wausau, WI (PRWEB) , ... June 23, 2016 ... ... probiotic supplements, is pleased to announce the launch of their brand, UP4™ Probiotics, ... supplements for over 35 years, is proud to add Target to its list ...
Breaking Biology Technology: